- Home
- ALPS vs MBOT Comparison
ALPS vs MBOT Comparison
Compare ALPS & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALPS | MBOT |
|---|---|---|
| Founded | 2017 | 2010 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.1M | 114.9M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | ALPS | MBOT |
|---|---|---|
| Price | $0.61 | $1.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 29.0K | ★ 1.1M |
| Earning Date | 07-24-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $119.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.56 | $1.60 |
| 52 Week High | $1.72 | $4.62 |
Technical Indicators
Market Signals| Indicator | ALPS | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 36.42 | 42.92 |
| Support Level | N/A | $1.65 |
| Resistance Level | $0.77 | $2.21 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 17.66 | 28.12 |
Price Performance
Historical ComparisonAbout ALPS ALPS Group Inc Ordinary Share
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.